CESR Chimes In On OTC Debate

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

CESR Chimes In On OTC Debate

Eddy Wymeersch, chairman of the Committee of European Securities Regulators, called for greater transparency and more disclosure in over-the-counter derivatives this week at the Global ABS summit in London.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article